Indiana University Foundation, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1820-01-20

Employees: 10K

Market Cap: -

Website: http://www.indiana.edu

Clinical Trials

A Study to Assess the Effect of Y-90 Therapy on Non-target/Background Liver

Not Applicable

Terminated

Conditions: HCC
Liver Cancer

Interventions: Radiation: MRI and HIDA scan

First Posted Date: 2016-11-17

Last Posted Date: 2020-09-25

Lead Sponsor: Indiana University

Target Recruit Count: 20

Registration Number: NCT02966223

Locations: 🇺🇸
Indiana University Hospital, Indianapolis, Indiana, United States

IU Health Krannert Personalized Medicine Study

Not Applicable

Terminated

Conditions: Coronary Artery Disease

Interventions: Other: Prescriber Access to Genetic Information

First Posted Date: 2016-11-04

Last Posted Date: 2020-07-28

Lead Sponsor: Indiana University

Target Recruit Count: 107

Registration Number: NCT02955121

Locations: 🇺🇸
Indiana University Health Methodist Hospital, Indianapolis, Indiana, United States

Methadone-Induced QT Interval Prolongation in a Narcotic Treatment Center

Completed

Conditions: QT Interval Prolongation

Interventions: Device: AliveCor handheld mobile ECG

First Posted Date: 2016-09-13

Last Posted Date: 2021-07-08

Lead Sponsor: Indiana University

Target Recruit Count: 170

Registration Number: NCT02898337

Locations: 🇺🇸
Eskenazi Health, Indianapolis, Indiana, United States

Bridging the Gap: Using Video Art to Document the Human Face of Disease & Predict Quality of Life Assessments in Brain Tumor Patients

Not Applicable

Completed

Conditions: Brain Tumors
Quality of Life
Animal Assisted Therapy

Interventions: Behavioral: Pet Therapy

First Posted Date: 2016-09-07

Last Posted Date: 2023-09-28

Lead Sponsor: Indiana University

Target Recruit Count: 13

Registration Number: NCT02890940

Health Outcomes of Teens Participating in Summer Employment Immersion Programs

Not Applicable

Completed

Conditions: Pediatric Obesity
Prediabetic State

Interventions: Behavioral: Measurement

First Posted Date: 2016-09-01

Last Posted Date: 2019-02-20

Lead Sponsor: Indiana University

Target Recruit Count: 83

Registration Number: NCT02886208

Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children

Phase 2

Terminated

Conditions: Glioblastoma Multiforme
Malignant Brain Tumor
High Grade Glioma
Anaplastic Astrocytoma

Interventions: Drug: Cabozantinib

First Posted Date: 2016-08-31

Last Posted Date: 2022-10-06

Lead Sponsor: Indiana University

Target Recruit Count: 4

Registration Number: NCT02885324

Locations: 🇺🇸
Riley Hospital for Children at IU Health, Indianapolis, Indiana, United States

Effect of Upright Patient Positioning on Intubation Success

Completed

Conditions: Intubation

Interventions: Procedure: Upright intubation

First Posted Date: 2016-08-31

Last Posted Date: 2016-08-31

Lead Sponsor: Indiana University

Target Recruit Count: 232

Registration Number: NCT02885298

Chlorthalidone in Chronic Kidney Disease

Phase 2

Completed

Conditions: Renal Insufficiency, Chronic
Hypertension

Interventions: Drug: Placebo
Drug: Chlorthalidone

First Posted Date: 2016-07-22

Last Posted Date: 2023-05-15

Lead Sponsor: Indiana University

Target Recruit Count: 160

Registration Number: NCT02841280

Locations: 🇺🇸
Indiana University School of Medicine, Division of Nephrology, Indianapolis, Indiana, United States

King Vision Video Laryngoscope Ambu (aBlade) System for Use in Children

Not Applicable

Completed

Conditions: King Vision Video Laryngoscope Intubation
Pediatric Anesthesia

Interventions: Device: King Vision video Laryngoscope

First Posted Date: 2016-07-22

Last Posted Date: 2020-06-02

Lead Sponsor: Indiana University

Target Recruit Count: 100

Registration Number: NCT02841189

Locations: 🇺🇸
Riley Hospital for Children at IU Health, Indianapolis, Indiana, United States

RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual Bleeding

Phase 2

Completed

Conditions: Venous Thromboembolism
Menstruation

Interventions: Drug: Apixaban
Drug: Rivaroxaban

First Posted Date: 2016-07-12

Last Posted Date: 2023-11-13

Lead Sponsor: Indiana University

Target Recruit Count: 19

Registration Number: NCT02829957

Locations: 🇺🇸
Eskenazi Health System, Indianapolis, Indiana, United States
🇺🇸
Indiana University Health Methodist Hospital, Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy